Wettig Thane

CIK 00018156381 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001815638

Recent Transactions

50 trades

Tax Payment
FIBROGEN INC$FGEN
Common Stock
2026-03-06$6.84/sh−277→ 24,403 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2026-02-03+60,000→ 60,000 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2025-12-06$8.42/sh−259→ 24,680 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-11-17$9.10/sh+2,700→ 24,939 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-11-13$9.18/sh+1,000→ 22,239 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2025-09-06$12.10/sh−248→ 21,239 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2025-06-06$7.83/sh−246→ 21,487 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-03-24$0.35/sh+145,000→ 543,329 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2025-03-06$0.39/sh−367→ 398,329 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2025-03-06$0.39/sh−22,038→ 397,915 total
Award
FIBROGEN INC$FGEN
Common Stock
2025-03-06+781→ 398,696 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2025-01-09+1,300,000→ 1,300,000 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-12-06$0.34/sh−2,363→ 419,953 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-09-06$0.39/sh−2,363→ 422,316 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-08-01$0.47/sh−20,840→ 424,679 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-06-22$1.13/sh−782→ 445,519 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-06-06$1.19/sh−2,255→ 446,301 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-05-01$1.17/sh−20,840→ 448,556 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-22$2.58/sh−782→ 469,396 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2024-03-07$1.91/sh+50,000→ 470,178 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-06$1.87/sh−4,209→ 419,723 total
Award
FIBROGEN INC$FGEN
Common Stock
2024-03-06+781→ 420,504 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-03-06$1.87/sh−326→ 420,178 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2024-02-21+834,000→ 834,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2024-02-21+166,000→ 423,932 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2024-02-01$2.37/sh−23,490→ 257,932 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-12-22$0.76/sh−819→ 281,422 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-12-06$0.58/sh−1,680→ 282,241 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-11-01$0.55/sh−21,841→ 283,921 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-09-22$0.79/sh−819→ 305,762 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2023-09-06$0.96/sh−1,680→ 306,581 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-08-07+200,000→ 308,261 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-08-07+300,000→ 300,000 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-23$16.53/sh−791→ 108,261 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$17.04/sh−472→ 112,681 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$17.04/sh−1,286→ 111,395 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$17.04/sh−472→ 110,338 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$17.04/sh−1,286→ 109,052 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-23$18.71/sh−905→ 110,653 total
Gift
FIBROGEN INC$FGEN
Common Stock
2023-03-20+1,000→ 1,000 total
Gift
FIBROGEN INC$FGEN
Common Stock
2023-03-20−2,343→ 108,310 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-10$20.20/sh−2,938→ 116,289 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-10$20.20/sh−4,731→ 111,558 total
Award
FIBROGEN INC$FGEN
COmmon Stock
2023-03-08+5,799→ 109,889 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-03-08+9,338→ 119,227 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-03-08$21.16/sh−6,265→ 104,090 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-02-21+25,000→ 110,355 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-02-21+42,000→ 42,000 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-23$15.80/sh−734→ 89,163 total
Sale
FIBROGEN INC$FGEN
Common Stock
2022-12-08$15.79/sh−382→ 89,897 total

Companies

FIBROGEN INC
Director, CEO
$FGEN

Recent Filings

Address

C/O KYNTRA BIO, INC. 350 BAY STREET, SUITE 100, #6009

SAN FRANCISCO, CA, 94133

View on SEC.gov